Real-World Osilodrostat Effectiveness and Safety in Nonpituitary Cushing Syndrome

20253 citationsJournal Articlehybrid Open Access

Authors

Osilodrostat is a suitable treatment for endogenous Cushing syndrome of various non-pituitary etiologies.

Published in: The Journal of Clinical Endocrinology & Metabolism

Field-Weighted Citation Impact: 3.90